AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Critical Metals, the core belief is that Tanbreez and its broader Greenland platform can eventually convert today’s very small revenue base and sizeable losses into a meaningful rare earths business. The acquisition of the Ocean Endeavour and the US$240.96 million shelf capacity both play directly into the near term catalysts and risks. On one hand, the vessel could help de risk execution by bundling housing and logistics into a single asset, potentially supporting drilling progress, pilot work and offtake credibility. On the other, it adds capital intensity and layers more dependence on Greenlandic approvals at a time when the company is unprofitable, has recently been removed from key indices and has already diluted shareholders. The shelves reinforce that further equity issuance remains a live possibility.
However, investors should be aware of how future dilution could affect their stake in the story. Upon reviewing our latest valuation report, Critical Metals' share price might be too optimistic.Explore 11 other fair value estimates on Critical Metals - why the stock might be worth over 4x more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com